National CineMedia (NASDAQ:NCMI – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at Benchmark in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $8.00 price objective on the business services provider’s stock. Benchmark’s price target would suggest a potential upside of 16.79% from the stock’s previous close.
Several other equities research analysts have also recently weighed in on NCMI. B. Riley upped their price target on National CineMedia from $7.50 to $8.50 and gave the stock a “buy” rating in a research note on Friday, August 16th. Wedbush reissued a “neutral” rating and set a $6.00 price objective on shares of National CineMedia in a report on Tuesday, August 6th. Finally, Barrington Research raised National CineMedia from a “market perform” rating to an “outperform” rating and set a $7.50 target price on the stock in a research report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, National CineMedia currently has an average rating of “Hold” and a consensus price target of $7.50.
Read Our Latest Research Report on NCMI
National CineMedia Trading Down 1.7 %
National CineMedia (NASDAQ:NCMI – Get Free Report) last posted its earnings results on Monday, August 5th. The business services provider reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.01). The business had revenue of $54.70 million during the quarter, compared to the consensus estimate of $49.87 million. National CineMedia had a return on equity of 3.50% and a net margin of 78.04%. During the same period in the previous year, the business earned ($0.07) earnings per share. As a group, sell-side analysts anticipate that National CineMedia will post -0.02 earnings per share for the current year.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the company. SG Americas Securities LLC bought a new stake in National CineMedia during the second quarter valued at about $56,000. Fermata Advisors LLC bought a new stake in National CineMedia during the 2nd quarter valued at approximately $92,000. Bayesian Capital Management LP purchased a new position in National CineMedia in the 1st quarter worth approximately $104,000. Oppenheimer Asset Management Inc. boosted its stake in National CineMedia by 38.9% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 23,897 shares of the business services provider’s stock worth $123,000 after purchasing an additional 6,690 shares during the period. Finally, The Manufacturers Life Insurance Company purchased a new stake in National CineMedia during the 2nd quarter valued at approximately $124,000. Hedge funds and other institutional investors own 69.49% of the company’s stock.
About National CineMedia
National CineMedia, Inc, through its subsidiary, National CineMedia, LLC, operates cinema advertising network in North America. It engages in the sale of advertising to national, regional, and local businesses in Noovie, a cinema advertising and entertainment show seen on movie screens; and sells advertising on its Lobby Entertainment Network, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theatre lobbies.
Featured Stories
- Five stocks we like better than National CineMedia
- Conference Calls and Individual Investors
- See Why Oracle’s Cloud Infrastructure Growth Demands Attention
- Short Selling: How to Short a Stock
- Darden Restaurants Is on the Verge of a Significant Breakout
- How to Use the MarketBeat Excel Dividend Calculator
- Onsemi Could Be Set Up For a Solid Rebound: Here’s Why
Receive News & Ratings for National CineMedia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National CineMedia and related companies with MarketBeat.com's FREE daily email newsletter.